Imaging of the endothelial dysfunction in coronary atherosclerosis

European Journal of Nuclear Medicine

Volumn 28, Issue 10, 2001, Pages 1567-1578

  Mrkic, James ^a   Saunders, Brian R ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Atherosclerosis; Endothelium; Imaging; Myocardium; Vasodilation

Indexed keywords

ACETYLCHOLINE; ARGININE; BRADYKININ; CARBACHOL; CELL ADHESION MOLECULE; CONTRAST MEDIUM; DIPYRIDAMOLE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; ENDOTHELIUM DERIVED RELAXING FACTOR; GADOLINIUM PENTETATE; GADOLINIUM PENTETATE MEGLUMINE; INTERCELLULAR ADHESION MOLECULE 1; METHACHOLINE; N(G) METHYLARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR; SEROTONIN; SUBSTANCE P; TECHNETIUM 99M; THALLIUM 201; TISSUE PLASMINOGEN ACTIVATOR; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ANGIOCARDIOGRAPHY; ARTERY ENDOTHELIUM; BLOOD VESSEL FUNCTION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE MARKER; DOPPLER ECHOCARDIOGRAPHY; EARLY DIAGNOSIS; ENDOTHELIUM LESION; HEART MUSCLE METABOLISM; HEART MUSCLE TENSION; HUMAN; INTERMETHOD COMPARISON; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING; VEIN OCCLUSION PLETHYSMOGRAPHY;

BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; CORONARY CIRCULATION; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; HUMANS;

EID: 0034784802     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590100528     Document Type: Article

References (100)

1. Non-invasive strategies for the estimation of cardiac risk in stable chest pain patients
2. Coronary angioplasty versus medical therapy for angina: The second Randomised Intervention Treatment of Angina (RITA-2) trial
3. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease
4. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy
5. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: Meta-analysis of randomised controlled trials
6. Twenty-two-year follow-up in the VA Cooperative Study of Coronary Artery Bypass Surgery for Stable Angina
7. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation
8. Strategic targeting of atherosclerotic lesions
9. Endothelial dysfunction: Does it matter? Is it reversible?
10. Endothelial dysfunction plays a dynamic role in coronary artery disease
11. Endothelial dysfunction associated with left ventricular diastolic dysfunction in patients with coronary heart disease
12. Positron emission tomography and the changing paradigm in coronary artery disease
13. Cholesterol-lowering treatment is associated with improvement in coronary vascular remodelling and endothelial function in patients with normal or mildly diseased coronary arteries
14. Testing for endothelial dysfunction
15. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease
16. Atherosclerosis
17. 'POPE': Predicting outcome by plaque evaluation
18. The pathogenesis of atherosclerosis: A perspective for the 1990s
19. Endothelium and control of vascular function
20. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
21. A technique to investigate surface morphology and endothelial cell replication of small arteries; a study in acute angiotensin-induced hypertension
22. Arterial abnormalities in the offspring of patients with premature myocardial infarction
23. The role of endothelium in cardiovascular homeostasis and diseases
24. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia
25. Short-term cholesterol lowering decreases in size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease
26. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease
27. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis
28. Effects of short term reduction in serum cholesterol with simvastatin in patients with stable angina pectoris and mild to moderate hypercholesterolemia
29. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve
30. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification
31. Myocardial perfusion and regression of coronary artery disease in patients on a regimen of intensive physical exercise and low fat diet
32. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
33. Coronary angiographic changes with lovastatin therapy: The monitored atherosclerosis regression study (MARS)
34. Biological significance of endogenous methylargines that inhibit nitric oxide synthase
35. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits
36. Endogenous nitric oxide synthase inhibitor. A novel marker of atherosclerosis
37. Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia
38. Novel mechanism for endothelial dysfunction. Dysregulation of dimethylarginine dimethylaminohydrolase
39. The role of endothelin in coronary atherosclerosis
40. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans
41. Endogenous tissue-type plasminogen activator and risk of myocardial infarction
42. Prospective study of endogenous tissue plasminogen activator and risk of stroke
43. Increased fibrinolytic activity in the intima of atheromatous coronary arteries: Protection at a price
44. Von Willebrand factor. A marker of endothelial damage?
45. Von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
46. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) Study
47. Increased levels of soluble P-selectin in hypercholesterolemic patients
48. Circulating endothelial cell/leukocyte adhesion molecules in atherosclerosis
49. Plasma concentrations of soluble intercellular adhesion molecule 1 and risk of future myocardial infarction in apparently healthy men
50. Measurement from arteriograms of regional myocardial bed size distal to any point in the coronary arterial tree for assessing anatomic area at risk
51. Spatial heterogeneity of myocardial perfusion and metabolism
52. Quantitative assessment of regional myocardial blood flow using oxygen-15-labelled water and PET: A multi-centre evaluation in Japan
53. Heterogeneities in myocardial flow and metabolism: Exacerbation with abnormal excitation
54. Molecular and particulate depositions for regional myocardial flows in sheep
55. New concepts and paradigms in cardiovascular medicine: The non-invasive management of coronary artery disease
56. Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by non-invasive positron emission tomography
57. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries
58. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease
59. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis
60. Evidence of endothelial dysfunction of epicardial coronary arteries in patients with immunohistochemically proven myocarditis
61. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans
62. Abnormal endothelium-dependent vascular reaction in patients with essential hypertension
63. Angiographically silent atherosclerosis detected in intravascular ultrasound in patients with familial hypercholesterolemia and familial combined hyperlipidemia: Correlation with high density lipoproteins
64. Diffuse intimal thickening of coronary arteries in patients with coronary spastic angina
65. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy
66. Coronary flow velocity changes after intravenous dipyridamole infusion: Measurements using intravascular Doppler guide wire. A documentation of flow inhomogeneity
67. Correlation of poststenotic hyperemic coronary flow velocity and pressure with abnormal stress myocardial perfusion imaging in coronary artery disease
68. Effect of exercise on coronary endothelial function in patients with coronary artery disease
69. Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy
70. Regional myocardial blood volume and flow: First-pass MR imaging with polylysine-Gd-DTPA
71. Quantification of myocardial perfusion with FAST sequence and Gd bolus in patients with normal cardiac function
72. A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging
73. Non-invasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging
74. Non-invasive coronary vessel wall and plaque imaging with magnetic resonance imaging
75. Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging
76. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
77. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
78. Close relationship of endothelial function in the human coronary and peripheral circulations
79. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease
80. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis
81. Coronary flow reserve is impaired in young men with hypercholesterolemia
82. Coronary flow reserve in young men with familial combined hypercholesterolemia
83. Early impairment of coronary flow reserve in young men with borderline hypertension
84. In vivo LDL oxidation relates to coronary reactivity in young men
85. Influence of cardiovascular risk profile on coronary flow reserve in healthy young men
86. Reduced myocardial flow reserve relates to increased carotid intima-media thickness in healthy young men
87. Different endothelial mechanisms involved in coronary responses to known vasodilators
88. Flow-induced release of endothelium-derived relaxing factor
89. The role of myocardial perfusion imaging in vascular endothelial dysfunction
90. Non-invasive characterization of cardiac microvascular disease by nuclear medicine using single-photon emission tomography
91. Effect of L-argine administration on myocardial thallium-201 perfusion during exercise in patients with angina pectoris and normal coronary angiograms
92. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
93. Blood-tissue transport of substrates in the heart: Studies by single circulation tracer dilution
94. Tc-99m-Ap4A for early gamma scintigraphic visualization of experimental atherosclerotic lesions
95. L-Argine during long-term ischemia: Effects of cardiac function, energetic metabolism and endothelial damage
96. The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in Finnish population
97. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy